Insulin-like growth factor II mediates resveratrol stimulatory effect on cathepsin D in breast cancer cells

References

• Aziz MH, Kumar R, Ahmad N. Cancer chemoprevention by resveratrol: In vitro and in vivo studies and the underlying mechanisms. Int J Oncol 2003; 23: 17–28
   PubMed Web of Science ®Google Scholar
• Berchem G, Glondu M, Gleizes M, Brouillet JP, Vignon F, Garcia M, Liaudet-Coopman E. Cathepsin D affects multiple tumor progression steps in vivo: Proliferation, angiogenesis and apoptosis. Oncogene 2002; 21: 5951–5955
   PubMed Web of Science ®Google Scholar
• Bhat KP, Pezzuto JM. Cancer chemopreventive activity of resveratrol. Ann NY Acad Sci 2002; 957: 210–229
   PubMed Web of Science ®Google Scholar
• Cavailles V, Augereau P, Rochefort H. Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells. Proc Natl Acad Sci 1993; 90: 203–207
   PubMed Web of Science ®Google Scholar
• Claussen M, Kubler B, Wendland M, Neifer C, Schmidt B, Zapf J, Braulke T. Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D. Endocrinology 1997; 138: 3797–3803
   PubMed Web of Science ®Google Scholar
• Conover CA, De León DD. Acid-activated insulin-like growth factor binding protein-3 proteolysis in normal and transfected cells. Role of Cathepsin D. J Biol Chem 1994; 269: 7076–7080
   PubMed Web of Science ®Google Scholar
• Daimon M, Johnson TR, Ilan J. The third IGF-II promoter specifies transcription of three transcripts out of five in human placenta. Mol Reprod Dev 1992; 33: 413–417
   PubMed Web of Science ®Google Scholar
• Damianaki A, Bakogeorgou E, Kampa M, Notas G, Hatzoglou A, Panagiotou S, Gemetzi C, Kouroumalis E, Marti PM, Castanas E. Potent inhibitory action of red wine polyphenols on human breast cancer cells. J Cell Biochem 2000; 78: 429–441
   PubMed Web of Science ®Google Scholar
• De León DD, Asmerom Y. Quantification of insulin-like growth factor I without interference by IGF binding proteins. Endocrinology 1997; 138: 2199–2202
   PubMed Web of Science ®Google Scholar
• De Leon D, Issa N, Nainani S, Asmerom Y. Reversal of cathepsin D routing modulation in MCF-7 breast cancer cells expressing antisense insulin-like growth factor II. Horm Metab Res 1999; 31: 142–147
   PubMed Web of Science ®Google Scholar
• De Leon D, Terry C, Asmerom Y, Nissley SP. Insulin-like growth factor II modulates the routing of cathepsin D in MCF-7 breast cancer cells. Endo 1996; 137: 1851–1859
   PubMed Web of Science ®Google Scholar
• Dong Z. Molecular mechanism of the chemopreventive effect of resveratrol. Mutat Res 2003; 523-524: 145–150
   PubMed Web of Science ®Google Scholar
• El-Mowafy AM, Alkhalaf M. Resveratrol activates adenylyl-cyclase in human breast cancer cells: A novel, estrogen receptor-independent cytostatic mechanism. Carcinogenesis 2003; 24: 869–873
   PubMed Web of Science ®Google Scholar
• Faridi JS, Mohan S, DeLeon DD. Modulation of cathepsin D routing by IGF-II involves IGF-II binding to the IGF-II/M6P receptor in MCF-7 breast cancer cells. Growth Factors 2004; 22: 169–177
   PubMed Web of Science ®Google Scholar
• Garcia D, Derocq D, Pujol P, Rochefort H. Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. Oncogene 1990; 5: 1809–1814
   PubMed Web of Science ®Google Scholar
• Gehm BD, Levenson AS, Liu A, Lee EJ, Amudsen BM, Cushman M, Jordan VC, Jameson JL. Estrogenic effects of resveratrol in breast cancer cells expressing mutant and wild-type estrogen receptors: Role of AF-1 and AF-2. J Steroid Biochem Mol Biol 2004; 88: 223–234
   PubMed Web of Science ®Google Scholar
• Glondu M, Coopman P, Laurent-Matha V, Garcia M, Rochefort H, Liaudet-Coopman E. A mutated cathepsin D devoid of its catalytic activity stimulates the growth of cancer cells. Oncogene 2001; 20: 6920–6929
   PubMed Web of Science ®Google Scholar
• Leto G, Tumminello FM, Crescimanno M, Flandina C, Gebbia N. Cathepsin D expression levels in non-gynecological solid tumors: Clinical and therapeutic implications. Clin Exp Metastasis 2004; 21: 91–106
   PubMed Web of Science ®Google Scholar
• Liaudet E, Garcia M, Rochefort H. Cathepsin D maturation and its stimulatory effect on metastasis are prevented by addition of KDEL retention signal. Oncogene 1994; 9: 1145–1154
   PubMed Web of Science ®Google Scholar
• Mathieu M, Rochefort H, Barenton B, Prebois C, Vignon F. Interactions of cathepsin D and insulin-like growth factor II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II. Mol Endocrinol 1990; 4: 1327–1335
   PubMedGoogle Scholar
• Mgbonyebi OP, Russo J, Russo IH. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int J Oncol 1998; 12: 865–869
   PubMed Web of Science ®Google Scholar
• Mineo R, Fichera E, Liang SJ, Fujita-Yamaguchi Y. Promoter usage for insulin-like growth factor II in cancerous and benign human breast, prostate, and bladder tissues and confirmation of a 10th exon. Biochem Biophys Res Commun 2000; 268: 886–892
   PubMed Web of Science ®Google Scholar
• Montcourrier P, Silver IA, Farnoud R, Bird I, Rochefort H. Breast cancer cells have a high capacity to acidify extracellular milieu by a dual mechanism. Clin Exp Metastasis 1997; 15: 382–3892
   PubMed Web of Science ®Google Scholar
• Pozo-Guisado E, Lorenzo-Benayas MJ, Fernandez-Salguero PM. Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: Relevance in cell proliferation. Int J Cancer 2004; 109: 167–173
   PubMed Web of Science ®Google Scholar
• Rochefort H, Cavailles V, Augereau P, Capony F, Maudelonde T, Touitou I, Garcia M. Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer. J Steroid Biochem 1989; 34: 177–182
   PubMedGoogle Scholar
• Rochefort H, Garcia M, Glondu M, Laurent V, Liaudet E, Rey JM, Roger P. Cathepsin D in breast cancer: Mechanisms and clinical applications, a 1999 overview. Clinica Quimica Acta 2000; 291: 157–170
   PubMed Web of Science ®Google Scholar
• Ruibal A, Arias JI. Axillary lymph node involvement in hormone-independent breast carcinomas. Med Clin 2004; 123: 50–52
   PubMed Web of Science ®Google Scholar
• Takahashi T, Tang J. Cathepsin D from porcine and bovine spleen. Methods Enzymol 1981; 80: 565–581
   PubMedGoogle Scholar
• Vetvika V, Benes P, Fusek M. Procathepsin D in breast cancer: What do we know? Effects of ribozymes and others inhibitors. Cancer Gene Ther 2002; 9: 854–863
   PubMed Web of Science ®Google Scholar
• Vyas S, Asmerom Y, De Leon DD. Resveratrol regulates IGF-II in breast cancer cells. Endocrinology 2005, published July 21, 2005 as doi:10.1210/en.2004-1344
   Google Scholar
• Xing W, Archer T. Upstream stimulatory factors mediate estrogen receptor activation of the cathepsin D promoter. Mol Endocrinol 1998; 1310–1321
   PubMedGoogle Scholar